We describe a case of Syringocystadenoma papilliferum (SCAP) with keratinizing squamous epithelium in a 26-year-old female presenting with a dark brown to black nodule on her forehead. After surgical excision, the specimen was examined immunohistochemically using antibodies against cytokeratin (CK) 1, 8, 10, 14, 17, 18  and 19. Within the keratinizing squamous  epithelium, CK1, 10, 14 and 17 were present, whereas the other CKs were absent. Based on CK expression, keratinizing squamous epithelium in SCAP seems to differentiate towards the infrainfundibulum.
Introduction
Syringocystadenoma papilliferum (SCAP) is a skin tumour arising from pluripotent primary epithelial germ cells. 1 Its histogenesis is unclear. We report a case of SCAP with keratinizing squamous epithelium in which an immunohistochemical study of the cytokeratins (CKs) present in the tumour using antibodies against CK1, 8, 10, 14, 17, 18 and 19 was performed. To our knowledge there is only one published immunohistochemical study of CKs in SCAP, 2 but this did not report on CK expression in the keratinizing squamous epithelium.
Case report
A 26-year-old female presented with a dark brown to black nodule on her forehead. The lesion was surgically excised. The specimen was fixed in formalin, embedded in paraffin and stained with haematoxylin and eosin. Serially cut sections were studied immunohistochemically.
The following anti-keratin antibodies were used in this study: 34βB4 (CK1), 3 DC10 (CK8 and 18), 4 LHP1 (CK10), 3 LL002 (CK14), 3 E3 (CK17), 3 5D3 (CK18) 5 and b170 (CK19) 3 (Novocastra Laboratories Ltd, Newcastleupon-Tyne, UK). A labelled streptoavidinbiotin method (LSAB, Dako, Carpentaria, CA, USA) was used as previously reported. 3 Normal skin from the face served as a control.
The CK expression demonstrated in the pilosebaceous apparatus and SCAP has been published in a previous report. 3 Within the keratinizing squamous epithelium, a keratinous cyst with keratohyaline granules (epidermoid or infundibular keratinization) was positive for CK1 and CK10 (Fig. 1 ). The basal (outermost) cells in the keratinizing squamous epithelium were positive for CK14. The keratinous cyst and some parts of the keratinizing squamous epithelium were positive for CK17 (Fig. 2 ). The other cytokeratins tested for (CK8, 18 and 19) were not expressed in the keratinizing squamous epithelium.
Within the tubular cystic lesions, the basal cells were positive for CK14 and 17, and the luminal cells were positive for CK 8, 18 and 19.
Discussion
A light microscopic study has revealed that the tumour parenchyma of SCAP extends downwards, from the interfollicular epidermis to the uppermost area of the hair follicles above the sebaceous duct and intrafollicular duct of the apocrine sweat glands. 6 In the present case, CK1 and CK10, which are present in the follicular infundibulum, were found in a keratinous cyst within the keratinizing squamous epithelium, suggesting that this area had infundibular characteristics.
In the previous study, 3 CK17, which is a hyperproliferative and contractile activity marker, was expressed in the suprabasal cells of the infrainfundibulum and in the sebaceous duct. CK17 has also been demonstrated previously in myoepithelial cells in the secretory portion of sweat glands. 7 In this study, CK17 was present in keratinizing squamous epithelium, suggesting that this area differentiates toward infrainfundibulum. Overall, the tubular cystic lesions had a similar CK expression to that in the secretory portion of sweat glands, as has been previously reported. 2 In conclusion, CK expression within the squamous epithelium associated with SCAP was similar to that of the infrainfundibulum. This is consistent with the results of a previous report, 7 and suggests that SCAP shows a broad, diversified heterogeneous spectrum of differentiation towards the infrainfundibulum and secretory portion of the sweat glands. Further investigations are needed to study and compare CK expression in embryonic apocrine and eccrine glands in order to clarify the histogenesis of SCAP.
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